David Drobne

22PUBLICATIONS
79CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 11, 2026
Isolated perianal fistulizing Crohn's disease in contemporary clinical practice: a multicenter ECCO-CONFER cohort study.

|Mar 28, 2026
Strategies to Overcome Hematocrit and Volume Bias in Dried Blood Spot Analysis.

Panagiotis-Dimitrios Mingas, Matjaž Cirar, Iztok Grabnar

|Jan 28, 2026
Calprest ELISA vs. Liaison® Chemiluminescence: Evaluating Accuracy, Efficiency, and Clinical Utility in Fecal Calprotectin Testing.

Joško Osredkar, Nina Ekart, David Drobne

|Dec 08, 2025
High persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort study.

Živa Šubic, David Drobne, Gregor Novak

|Oct 29, 2025
Oxidative Stress-Related Biomarkers in Inflammatory Bowel Disease: Dual Tools for Remission Assessment and Prediction of Treatment Outcome.

Armando Tratenšek, Iztok Grabnar, David Drobne

|Sep 27, 2025
Development, Validation and Application of the Dried Blood Spot Analysis Method for the Determination of Ustekinumab in Patients with Inflammatory Bowel Disease.

Panagiotis-Dimitrios Mingas, Jurij Aguiar Zdovc, Iztok Grabnar

Pageof 4

Frequent Collaborators

6 joint publications

Jurij Hanžel

5 joint publications

Tomaž Vovk

4 joint publications

Iztok Grabnar

3 joint publications

Gregor Novak